Partner
Ehi Akhirome
Senior Associate, Samsara BioCapital
- Firm
- Samsara BioCapital
- Title
- Senior Associate
- Role
- Associate
- Known as
- Investor
Record updated 4 October 2026
About
Ehi Akhirome is an investor at Samsara BioCapital, focusing on opportunities in biotech and diagnostics. He joined the Samsara team in 2026, bringing over a decade of experience across financial services, medicine, and biomedical research. Prior to Samsara, Ehi spent four years as an investor at Norwest, where he helped build the healthcare venture team and advise portfolio companies as a board observer. His work supported over $200M in new investments, including deals with Ray Therapeutics, Zenas Biopharma, and Ouro Medicines (acq. by Gilead for $2.2B).
Is this you? Remove my profile